Renaissance Technologies - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 111 filers reported holding RECRO PHARMA INC in Q4 2019. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$392
-58.9%
836,017
-3.6%
0.00%0.0%
Q2 2023$954
-10.8%
867,217
-3.5%
0.00%0.0%
Q1 2023$1,069
-21.2%
898,717
-1.2%
0.00%
-50.0%
Q4 2022$1,356
-99.9%
909,817
-5.0%
0.00%0.0%
Q3 2022$1,561,000
+89.9%
957,932
-7.3%
0.00%
+100.0%
Q2 2022$822,000
-55.2%
1,033,400
+1.3%
0.00%
-50.0%
Q1 2022$1,836,000
-7.3%
1,020,000
-11.9%
0.00%0.0%
Q4 2021$1,981,000
-20.2%
1,158,200
-3.9%
0.00%
-33.3%
Q3 2021$2,482,000
-6.6%
1,204,988
+4.8%
0.00%0.0%
Q2 2021$2,657,000
-22.4%
1,150,273
-6.2%
0.00%
-25.0%
Q1 2021$3,422,000
-13.0%
1,226,375
-11.1%
0.00%0.0%
Q4 2020$3,932,000
+27.9%
1,379,785
-5.7%
0.00%
+33.3%
Q3 2020$3,074,000
-39.7%
1,463,888
+30.6%
0.00%
-25.0%
Q2 2020$5,101,000
-49.3%
1,121,100
-9.0%
0.00%
-60.0%
Q1 2020$10,061,000
-46.1%
1,231,400
+20.9%
0.01%
-28.6%
Q4 2019$18,676,000
+97.6%
1,018,862
+19.4%
0.01%
+75.0%
Q3 2019$9,451,000
+20.8%
853,000
+10.9%
0.01%
+14.3%
Q2 2019$7,824,000
+79.9%
769,300
+3.7%
0.01%
+75.0%
Q1 2019$4,349,000
+0.3%
742,200
+21.5%
0.00%
-20.0%
Q4 2018$4,337,000
+27.0%
610,800
+27.1%
0.01%
+25.0%
Q3 2018$3,416,000
-42.2%
480,500
-35.4%
0.00%
+33.3%
Q2 2018$5,906,000
+47.9%
743,900
+105.2%
0.00%
-25.0%
Q1 2018$3,992,000
+253.6%
362,600
+197.2%
0.00%
+300.0%
Q4 2017$1,129,000
+27.1%
122,000
+23.4%
0.00%0.0%
Q3 2017$888,000
+25.8%
98,900
-1.5%
0.00%0.0%
Q2 2017$706,000
+27.2%
100,400
+58.1%
0.00%0.0%
Q1 2017$555,000
+275.0%
63,500
+245.1%
0.00%
Q4 2016$148,000
-48.3%
18,400
-43.2%
0.00%
-100.0%
Q3 2016$286,00032,4000.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders